Skip to main content

Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding. 

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 381 - 400 of 757
Cases and Proceedings

Watson Pharmaceuticals, Inc. and Andrx Corporation., In the Matter of

A consent order settled charges that Watson Pharmaceuticals, Inc.’s proposed $1.9 billion acquisition of Andrx Corporation, would have likely led to competitive problems in the markets for 13 generic drug products. Watson was required to end its marketing agreements with Interpham Holdings, divest Andrx’s right to develop, make, and market generic extended release tablets that correct the effects of type 2 diabetes, and divest Andrx’s rights and assets related to the developing and marketing of 11 generic oral contraceptives.

There is a related federal proceeding and two related administrative proceedings:

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610139
Docket Number
C-4172
Cases and Proceedings

Puerto Rico Association of Endodontists, Corp., In the Matter of

The Commission approved a final consent order settling charges alleging that thirty competing association members acted unlawfully by agreeing to set the prices they would charge dental insurance plans, and by refusing to deal with plans that would not accept the collectively determined prices.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0510170
Cases and Proceedings

Boston Scientific Corporation and Guidant Corporation, In the Matter of

The consent order settles charges that the $27 billion acquisition of Guidant Corporation by Boston Scientific Corporation would harm competition and consumers in several significant medical device markets. Guidant Corporation by Boston Scientific Corporation are the largest market shareholders in several coronary medical device markets in the U.S., together accounting for 90% of the U.S. PTCA balloon catheter market and 85% of the U.S. coronary guidewire market.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610046
Displaying 381 - 400 of 757
Return to top